Injectable hydrogel filled into porous scaffolds combined with ultrasound-controlled drug release
The Knee · 2026
DOI: 10.1016/j.knee.2026.104633 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Knee, 2026. Verfasst von Yuhong Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, China. Hauptthemen laut MEDLINE: Diclofenac, Tissue Scaffolds, Hydrogels, Drug Delivery Systems. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Zhejiang Province Public Welfare Technology Application Research Project.
Abstract (Originalsprache)
BACKGROUND: Injectable hydrogels can form in situ at bone defect sites, serving as filling materials, drug delivery carriers, and cell growth scaffolds. However, their limited mechanical strength and uncontrollable drug release restrict their application in orthopedics. This study integrates injectable hydrogels into 3D-printed porous scaffolds to meet the biomechanical demands of orthopedic applications. Ultrasound was employed to modulate hydrogel drug release, enabling on-demand delivery. METHODS: Diclofenac sodium-loaded injectable hydrogel (Gel-DS) were incorporated into 3D-printed polylactic acid (PLA) porous scaffolds. The system was optimized via rheological and injectability tests; cell biocompatibility was assessed using CCK-8 assays. In vitro drug release under ultrasonic stimulation was analyzed, and in vivo therapeutic effect on arthritis rats was evaluated. RESULTS: PLA porous scaffolds (1.00-mm spacing) offer high printing accuracy, adequate filling capacity, enhanced mechanical performance, and cytocompatibility. Ultrasound exposure showed negligible adverse effects on cellular activity. Porous structures increase specific surface area to regulate drug release kinetics. Ultrasound shifted the drug release mechanism from diffusion combined with erosion to erosion-dominated, increasing cumulative release at 8 h from 26.0% to 46.8%. In carrageenan-induced arthritic rats, Gel-DS combined with ultrasound treatment restored knee diameter to near-healthy levels (12.92 mm vs. 13.00 mm in the healthy group) and increased paw withdrawal threshold (26.0 g vs. 6.0 g in the untreated model group) demonstrating significant anti-edematous and analgesic effects. CONCLUSIONS: The combination of injectable hydrogels with 3D-printed scaffolds demonstrates an effective strategy for bone defect repair, and integration with ultrasound enables long-term controlled and on-demand drug delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, China.
- Department of Orthopaedics, No. 903 Hospital of PLA Joint Logistic Support Force, Hangzhou, China.
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, China. Electronic address: yangyan10@zjut.edu.cn.
Förderung
- Zhejiang Province Public Welfare Technology Application Research Project
Zitieren
APA
Xu, Y., Zhao, P., Lin, Q., Zhang, H., Shen, L., Ye, Y., & Yang, Y. (2026). Injectable hydrogel filled into porous scaffolds combined with ultrasound-controlled drug release. The Knee. https://doi.org/10.1016/j.knee.2026.104633
Vancouver
Xu Y, Zhao P, Lin Q, Zhang H, Shen L, Ye Y, et al. Injectable hydrogel filled into porous scaffolds combined with ultrasound-controlled drug release. The Knee. 2026. doi:10.1016/j.knee.2026.104633
BibTeX
@article{Xu2026,
author = {Xu, Yuhong and Zhao, Pingping and Lin, Qu and Zhang, Haozheng and Shen, Lian and Ye, Youcheng and Yang, Yan},
title = {Injectable hydrogel filled into porous scaffolds combined with ultrasound-controlled drug release},
journal = {The Knee},
year = {2026},
doi = {10.1016/j.knee.2026.104633}
}
EUVIMED